BC
CCXI

Broadfin Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Broadfin Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-800,000
Closed -$3.6M – 80
2014
Q3 		$3.6M Sell
800,000
-250,000
-24% -$1.32M 0.38% 57
2014
Q2 		$6.14M Hold
1,050,000
– – 0.6% 45
2014
Q1 		$6.96M Buy
1,050,000
+16,332
+2% +$113K 0.67% 42
2013
Q4 		$5.99M Buy
+1,033,668
New +$5.33M 0.79% 37

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Broadfin Capital's CCXI Position: Q4 2014 in Review

Broadfin Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2014, closing a stake of 800,000 shares — an estimated $3.6M sold.

Broadfin Capital first reported a position in CCXI in Q4 2013 and held it in 4 quarters. The position peaked at $6.96M in Q1 2014. 65 funds tracked by Wall St. Rank hold CCXI as of Q4 2014.

  • Broadfin Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2014 after selling out during the quarter.
  • Broadfin Capital sold 800,000 ChemoCentryx, Inc. shares in Q4 2014, an estimated $3.6M.
  • Broadfin Capital first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 4 quarters.
  • Broadfin Capital's ChemoCentryx, Inc. position peaked at $6.96M in Q1 2014.
  • 65 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2014.

Based on Broadfin Capital's 13F filing for Q4 2014, filed 17 Feb 2015.